AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Advancements in dendritic cell vaccines for cancer therapy expected.
2003 MAY 14 - (NewsRx.com & NewsRx.net) -- Advancements in dendritic cell vaccine technology for the treatment of cancer are expected.
According to a study from Germany and the United States, "A novel approach to vaccination against cancer is to exploit dendritic cells (DCs) as 'nature's adjuvants' and actively immunize cancer patients with a sample of their own DCs primed with tumor antigens. DC vaccination is, however, still at an early stage, slowed in part by the need to carry out research in humans. Nevertheless, valuable proofs of concept have been obtained with respect to the capacity of DCs to expand cancer-directed immune responses."
"The methods for preparing DCs are being improved continuously, and there are many opportunities to improve efficacy at the level of DC biology," said Gerold Schuler and colleagues at the University Hospital of Erlangen in Germany and Rockefeller University in ...
- Aastrom Biosciences Receives NIH Grant for Dendritic Cell Vaccine Research; --...
- Press release article from: PR Newswire September 15, 2003 700+ words
...production of completed dendritic cell-based vaccines...quantities of complex dendritic cell vaccines. This study...CPP business for dendritic cell production products...in Europe and the United States. For more information...
- Aastrom Biosciences Completes CE Mark Requirements for Third Dendritic Cell...
- Press release article from: PR Newswire August 21, 2003 700+ words
...Europe and the United States; sites evaluating the Company's dendritic cell production products...University in the United States, and University...business for dendritic cell production products...Europe and the United States. For more information...
- Dendritic cell-based vaccines for cancer therapy reviewed.(Brief Article)
- Newspaper article from: Cancer Weekly February 18, 2003 700+ words
...investigators in the United States explores the avenues of research into dendritic cell vaccines for the treatment...Biological Therapy (Dendritic cell-based vaccines and...major subject areas of Dendritic Cell Vaccine, Cancer Vaccine...
- Dendritic cell-based vaccines for cancer therapy reviewed.
- Newspaper article from: Cancer Vaccine Week February 17, 2003 700+ words
...investigators in the United States explores the avenues of research into dendritic cell vaccines for the treatment...Biological Therapy (Dendritic cell-based vaccines and...major subject areas of Dendritic Cell Vaccine, Cancer Vaccine...
- Notch signaling necessary but not sufficient for dendritic cell differentiation.
- Newspaper article from: Biotech Week January 14, 2004 700+ words
...progenitor cells (HPCs) and bone marrow stroma (BMS)," scientists in the United States explained. "However, the precise contribution of Notch in dendritic cell (DC) differentiation is controversial." "In two different experimental...
- Dendreon's Dendritic Cell Therapy Goes International; First Patients Treated At...
- Press release article from: Business Wire September 29, 1999 700+ words
...opening of the first dendritic cell processing center outside the United States, located in Japan...s proprietary dendritic cell isolation and enrichment...GMP production of dendritic cell therapies in the United States -- one at its satellite...
- BioPulse Announces New Dendritic Cell Cancer Vaccine.
- Press release article from: PR Newswire October 4, 2000 700+ words
...cell cancer vaccines. Dendritic cell cancer vaccines are...are actually offering dendritic cell therapy to the general public outside the United States. BioPulse believes...by other companies. Dendritic cell cancer vaccines use...
- Coley receives dendritic cell patent.(Coley Pharmaceutical Group Inc.)(Brief...
- Newspaper article from: BIOTECH Patent News August 1, 2002 700+ words
The United States Patent and Trademark Office granted United States Patent 6,429,199...activate dendritic cells. United States patent 6,429,199...companies who are developing dendritic cell technology and cancer...
Source: HighBeam Research, Advancements in dendritic cell vaccines for cancer therapy expected.